{"id":136302,"date":"2026-08-11T16:57:09","date_gmt":"2026-08-11T16:57:09","guid":{"rendered":"https:\/\/www.europesays.com\/ai\/136302\/"},"modified":"2026-08-11T16:57:09","modified_gmt":"2026-08-11T16:57:09","slug":"qaiax-launches-agi-smart-city-clinical-trial-q-men-digital-dna-veterans-first-for-america","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ai\/136302\/","title":{"rendered":"QAIAx Launches AGI Smart City Clinical Trial &#038; Q-Men Digital DNA (Veterans First for America)"},"content":{"rendered":"<p>            Video Content: QAIAx Microcities Clinical Trial (General Program Details)      <a href=\"https:\/\/s.yimg.com\/lo\/mysterio\/api\/323B23A78F81FE9D87D18ADAE6B4EC93DAD48782688FEB5EF1B0948E5E62DE65\/subgraphmysterio\/resizefit_w960;quality_80;format_webp\/https:%2F%2Fmedia.zenfs.com%2Fen%2Fglobenewswire.com%2F00aae4afb9d4a55016321a6b0b37a51c.jpg\" target=\"_blank\" rel=\"noopener noreferrer nofollow\"><img loading=\"lazy\" decoding=\"async\" src=\"data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/ywAAAAAAQABAAACAUwAOw==\" alt=\"QAIAx CT - (Clinical Trial Updates from Key Sponsor)\" height=\"644\" width=\"960\" class=\"yf-j98iil loader\"\/><\/a> QAIAx CT &#8211; (Clinical Trial Updates from Key Sponsor)                   <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\"><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=7ZK0ux86-ri9IEQopJPoHrmmTa5Vj6Q7BtrdkivB7V2bJrSB6bbJFv_4dSI3J0AcxlFyWLQ1J13OMF781F89oPVzBJz4RLsBsFO2a3NbwE_5ybrkYj-qK_30MjNN746r0yM3ZfPAlGCIhSF2nLM4ne1-vj9vCGlqYcuQqVgonnwz8u_B_hkNrIpcO9cqZ04H0UzqYJQnywWkw8_OH3rRTw==\" data-ylk=\"slk:CLINICAL%20TRIAL%20UPDATE;elm:context_link;itc:0;sec:content-canvas;source:content-canvas%20default\" data-yga=\"{&quot;yLinkText&quot;:&quot;CLINICAL TRIAL UPDATE&quot;,&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yTrafficOrigin&quot;:&quot;content-canvas default&quot;}\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">CLINICAL TRIAL UPDATE<\/a>\u00a0  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">RICHMOND, Va., Aug. 11, 2026 (GLOBE NEWSWIRE) &#8212; The smart health rehab cities program administration has unveiled an expanded deployment roadmap for its pioneering autonomous public health initiative for AI Smart Health sponsored communities, intended for military veterans and public workers in accordance with the Rehabilitation Act. QAIAx CT\u2014(ClinicalTrials.gov PRS ID <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Zk82WjAjrzpM4ILluhoMMkw4pbyn6POVtnjnb4YQFIOTo6EGBOB5dvNG2WPgcmMgeGzE9cb_9rw1R2Mla3dL_ndzcDWd9i1BxDWSu2u20F6Hv2pQOvHLWAu0KW-UkyQU\" data-ylk=\"slk:NCT07661823;elm:context_link;itc:0;sec:content-canvas;source:content-canvas%20default\" data-yga=\"{&quot;yLinkText&quot;:&quot;NCT07661823&quot;,&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yTrafficOrigin&quot;:&quot;content-canvas default&quot;}\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">NCT07661823<\/a>), a multi-year trial evaluates behavioral and mental health delivery within dome-enclosed &#8220;Microcities&#8221; managed by quantum AI and humanoid robotics living and learning with humans with common personal imperfections.<\/p>\n<p>Veterans First for America Fact Finding:<\/p>\n<p>(A) Early Enrollment &amp; Waiting List for VHA\/IHS\/DOL? (Visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=TPbnVx9z9AghlHotzAx2nNAu9rgCNnnLFmSeENtGpKAmogi_15eOzZRiT8PMmv5RXZPwSCMuR4hlJMKBf--X1Dhlx0GxO1oCUUrzfNfap-U=\" data-ylk=\"slk:vets-recovery.com;elm:context_link;itc:0;sec:content-canvas;source:content-canvas%20default\" data-yga=\"{&quot;yLinkText&quot;:&quot;vets-recovery.com&quot;,&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yTrafficOrigin&quot;:&quot;content-canvas default&quot;}\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">vets-recovery.com<\/a>)<\/p>\n<p>(B) Fastest Way to Get Officials Facts &amp; Updates about QAIAx CT? (Visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=MiQFZKYm8yxlar0IGXsCSeL6-QH6RGQJPYQQlbQgGc0HKMmi5JjwIp5zcZg8x4WG46zkAXgmZiqrgXhJXqLXSQ==\" data-ylk=\"slk:qaiax.org;elm:context_link;itc:0;sec:content-canvas;source:content-canvas%20default\" data-yga=\"{&quot;yLinkText&quot;:&quot;qaiax.org&quot;,&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yTrafficOrigin&quot;:&quot;content-canvas default&quot;}\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">qaiax.org<\/a>) <\/p>\n<p>(C) Other Clinical Trial Program Updates (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=lKIUoroyuD6QCIDcGQ-5vWgYld2yYerYdLRwCWWRqyU88Kg4Uu2sjN53J06q_5PY_nWbLaHC_1xvZtMj-J6Qph20Ky55YmCx-6UKWlOAvV6whidLfKP4iGOffifjYy2bQxBqmza5bK9I_VXLrkQoddcKE_DXQgGXFvHzPZruZ2qxT75wbWeMAKI212p4TXhy\" data-ylk=\"slk:read%20more;elm:context_link;itc:0;sec:content-canvas;source:content-canvas%20default\" data-yga=\"{&quot;yLinkText&quot;:&quot;read more&quot;,&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yTrafficOrigin&quot;:&quot;content-canvas default&quot;}\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">read more<\/a>)  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">Global SOFA Networks &amp; Localized Tracking  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">The trial targets an enrollment of 1,000,000 participants across a global network of 300 Microcities. Tentative international enclave locations are designated within sovereign military installations, tribal lands, and global special economic zones. Operations span participating allied nations bound by Status of Forces Agreements (SOFA) and bilateral treaties\u2014including <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=hPIKitjJBLNQcIzzhKKVOOMO8neSIWy__L3zMVoDOlj3UBgk7G7jg7RtoEAlgX4hxxTkjp7PiF-kJLsg_1Uf-KTHuHwmOKPZ3rIZosGr4UewZU4BW1UgiUVl3y3jaaIw\" data-ylk=\"slk:Great%20Britain;elm:context_link;itc:0;sec:content-canvas;source:content-canvas%20default\" data-yga=\"{&quot;yLinkText&quot;:&quot;Great Britain&quot;,&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yTrafficOrigin&quot;:&quot;content-canvas default&quot;}\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">Great Britain<\/a>, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=pQ8mHVkSDfJVdbc7MO9kFsusrtYHR2zwnlKxCSCMmT8PkArPnoNNuBUKgoGFKYVKjXzJ5J_88c9GPdo17ocFrXGVWdN0gwXWECsinegncZU=\" data-ylk=\"slk:Japan;elm:context_link;itc:0;sec:content-canvas;source:content-canvas%20default\" data-yga=\"{&quot;yLinkText&quot;:&quot;Japan&quot;,&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yTrafficOrigin&quot;:&quot;content-canvas default&quot;}\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">Japan<\/a>, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=DlR7koGL9AUnhyGCEfM4zQNAYr45VQFOFkHBwlJ9NIAGj7WzUz4gUdWx2U5HuoOH9oZXGWTgvb17uXVAcsjpVeZ0bABvEutXAibcdqeXVOMPV1bUdCo7zw2h3OyBrln3\" data-ylk=\"slk:Australia;elm:context_link;itc:0;sec:content-canvas;source:content-canvas%20default\" data-yga=\"{&quot;yLinkText&quot;:&quot;Australia&quot;,&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yTrafficOrigin&quot;:&quot;content-canvas default&quot;}\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">Australia<\/a>, EU member states, Arabic Gulf states, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Phd6lEv6XDgsxmmZpe0Tq3NK0EIbuIeU_2VrQE-ioRY7wlWqKxPTtLGOAHcfqqVi8s68tahifu1buitwCdaE4BO0y4IxenhMi81GwJtZNPMqA8PSslagufECZm00xPMx\" data-ylk=\"slk:African%20Union;elm:context_link;itc:0;sec:content-canvas;source:content-canvas%20default\" data-yga=\"{&quot;yLinkText&quot;:&quot;African Union&quot;,&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yTrafficOrigin&quot;:&quot;content-canvas default&quot;}\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">African Union<\/a> states, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=0INFaKLQRGWMyyc76paZxGwzEzgcwUJUyikeLFx0gGaUXBjhrEXYeFvQXkL4Y-b6q-ilLbP_GWUkpULzA_kTzrf1gfdvaGj5Bj8ZCoO5qw0=\" data-ylk=\"slk:India;elm:context_link;itc:0;sec:content-canvas;source:content-canvas%20default\" data-yga=\"{&quot;yLinkText&quot;:&quot;India&quot;,&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yTrafficOrigin&quot;:&quot;content-canvas default&quot;}\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">India<\/a>, and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=A9-7xQLdQHVXN8MbEqbbvxYlmDnTHqB5bHx6AbgGuy-FP0FrTN_ktmXq0ZigZf3GK8k7BlNEPg3Jufp9Ks9MAQdZRzIsgd_Syk5Juh3wvCg=\" data-ylk=\"slk:Brazil;elm:context_link;itc:0;sec:content-canvas;source:content-canvas%20default\" data-yga=\"{&quot;yLinkText&quot;:&quot;Brazil&quot;,&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yTrafficOrigin&quot;:&quot;content-canvas default&quot;}\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">Brazil<\/a>. These hubs operate under international digital data privacy security agreements, aligning with public health research studies on humans using AI. Upcoming local facilities are traceable via official public records on FindTreatment.gov. Entry onto the waiting list carries zero cost, with zero-fee scaling for low-income, veteran, and refugee applicants. Priority processing is granted to military veterans and public assistance recipients.  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">High-Yield Zone Sponsorship &amp; Dynamic Vending  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">Corporate, philanthropic, and government entities can establish customized enclaves hosting up to 3,000 occupants via site sponsor investments of $2,000,000 to $10,000,000 structured through Donor-Advised Funds. Sponsors retain naming rights and design specific thematic profiles like Sober City AI. Commercial vendor opportunities operate on a 5-year percentage lease structure requiring an 8% to 15% revenue split. Facilities scale dynamically based on occupancy, ranging from express kiosks at 1,650 residents to full-scale supermarkets, independent medical professional offices, and pharmacies at higher scales. All checkouts double as data-telemetry hubs tracking consumption patterns via biometric tokens.  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">The Q-Men Workforce Method: Income Multiplication  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">A core economic pillar is the Q-Men Workforce Project, profiled on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=0ruLW7PdKOi6MFRlqqxzZV4LhxbfocEh7McZFrwLDuUjvlW_aTbZCsyrs7fZqOphmjB-Y0ujDSTxrCdjo0H1H1IBCIeKqeuZ5tKt2QpNEbEanb4KgmssIvT4qZPFr_X04dgIACRssykWuFFDhW9YTJecBRe1pB6ahatsS_HPRH3hzRhpuGGNYWMF1G2Eeblk\" data-ylk=\"slk:Yahoo%20Finance;elm:context_link;itc:0;sec:content-canvas;source:content-canvas%20default\" data-yga=\"{&quot;yLinkText&quot;:&quot;Yahoo Finance&quot;,&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yTrafficOrigin&quot;:&quot;content-canvas default&quot;}\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">Yahoo Finance<\/a>. Under this method, human professionals train omni-AI humanoid agents to copy their exact technical skills. Operators license these digital surrogates to execute multiple client service orders simultaneously, multiplying normal human income by 2 to 20 times while dropping the manual work week to under 2 hours daily spent reviewing a procurement dashboard. <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=6fh5ZYNo1q2TH6NoIwkasFmC85iKrm7G-i7de8nOuODNjV4BEbQC2M3vHnD1owfrHXYaQQcf946fjXxvDKGBN_3Ik8W92u4Xxne1DG63FSI=\" data-ylk=\"slk:Q-Men%20Workforce%20Project;elm:context_link;itc:0;sec:content-canvas;source:content-canvas%20default\" data-yga=\"{&quot;yLinkText&quot;:&quot;Q-Men Workforce Project&quot;,&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yTrafficOrigin&quot;:&quot;content-canvas default&quot;}\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">Q-Men Workforce Project<\/a> on digital labor programming was raised by various tech news media outlets (e.g., <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=VdlFlDFWXCCtImjqvdG97NiqSoEzrJAWV0BecbeHmXVgUtu1gPoX8Fw6PBu8CgP8e4NnkeCUnddxjzWjFwixA_RHbokfh1w2YAKG8HPeubl8PhwunEScVpthJzCaOcSqhxNOVsa_OLLHav1ryD4xRA==\" data-ylk=\"slk:EWeek.com;elm:context_link;itc:0;sec:content-canvas;source:content-canvas%20default\" data-yga=\"{&quot;yLinkText&quot;:&quot;EWeek.com&quot;,&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yTrafficOrigin&quot;:&quot;content-canvas default&quot;}\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">EWeek.com<\/a>, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=adygxQFOEJHK61H2h1mYf-2F8BFJmJreVLqXmXVy4Ot28-iJhD02Vmul7OMNGnDLn5YeLj0ovy0Dapv_rHrPx2YxnIpj8YV7FSACpgytMfXEmdvAUucod9BMlzcNOEma8QYLkZ_HbiKynWIyQs4n62pO14B9nJLgGEJHRdHd2kc=\" data-ylk=\"slk:SOHU.com;elm:context_link;itc:0;sec:content-canvas;source:content-canvas%20default\" data-yga=\"{&quot;yLinkText&quot;:&quot;SOHU.com&quot;,&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yTrafficOrigin&quot;:&quot;content-canvas default&quot;}\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">SOHU.com<\/a>, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=UwfKQ_3KF-q-vO6-QObb_a-VBafM7TkUJJ1OKMQnPMNoyVE1U9CI2-0sIeVCLHewApuSH3l5iXzmgXWudoM0pNPDtB_-zOyXVpIpnlqWLP5zX_Qzvk3o0dvyKhKmDWGOexGm1fPjNBVWRCJb-jhdyu08LDDHhR2Y4T_vszX54Z_ZwAn4tONAWCvGbcn0qHx4jLfgeQWRvuxadgIZUFK3Ng==\" data-ylk=\"slk:GadgetReview;elm:context_link;itc:0;sec:content-canvas;source:content-canvas%20default\" data-yga=\"{&quot;yLinkText&quot;:&quot;GadgetReview&quot;,&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yTrafficOrigin&quot;:&quot;content-canvas default&quot;}\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">GadgetReview<\/a>, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=0ruLW7PdKOi6MFRlqqxzZQP6z4gD0PkESCLQPtoFTQxnywYUI_3c67lKYMQZ53WVsPj-PAkESCmHizB_USZaU8ByZfvD2IKwAmLDRFTWf9DyywHpFQqUsR0EwZqwFUg-2ajG7bOzYHoS-O0NumHdBbKz7Y2JJaXwWxKbv5zTstTe2H7l0uq_iCq-yujE5gpg\" data-ylk=\"slk:Yahoo%20Tech;elm:context_link;itc:0;sec:content-canvas;source:content-canvas%20default\" data-yga=\"{&quot;yLinkText&quot;:&quot;Yahoo Tech&quot;,&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yTrafficOrigin&quot;:&quot;content-canvas default&quot;}\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">Yahoo Tech<\/a>), focused on creating viable use cases involving AGI data stacks (digital DNA) lawfully and technically capable of being preserved for decades or centuries under a Government-use AGI license <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=wFFHW5JN1rWXCCAEPY1FKoQ_AMy8dew_QQGqMUODALM4ct4brsa3LhkxGYu1ckcxye5L-vj8VAeba8MGBrUHF-qWpWyiyHHteaaN4ok_1ly29YIaDAHHS0aPACpl8ZrupV5JlAmeXCgQSimFOcLmgMurVTaFHHkeYzAtibEgHbCibOg4swYlOD3xo-8nXH22-3t7rZOj2qCE5qNma8lB8HnS8zSUDNatLaB2oLrEFRvEIlgTXAEarmgJW1DbMNtx\" data-ylk=\"slk:patent%20framework;elm:context_link;itc:0;sec:content-canvas;source:content-canvas%20default\" data-yga=\"{&quot;yLinkText&quot;:&quot;patent framework&quot;,&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yTrafficOrigin&quot;:&quot;content-canvas default&quot;}\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">patent framework<\/a>.  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">Cyber Incident Mitigation &amp; Program Updates<br \/>Project administrators recently addressed an industry-wide AI security anomaly reported on major search engines and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=dQvlHN3Lgk2J-xz2S0DKqbh6uXM6v7DjH3ECNWNrNHlMeJrkmSK-HS0rQx9b-CXefxsHwdbYA4Id22oKpaCJrmmGdniHNJd3-tc5LdzsF0BvQmdXbS_vFVNpR16dvppvRF_wX0bu5AGcdtDB3U_wIg==\" data-ylk=\"slk:filed;elm:context_link;itc:0;sec:content-canvas;source:content-canvas%20default\" data-yga=\"{&quot;yLinkText&quot;:&quot;filed&quot;,&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yTrafficOrigin&quot;:&quot;content-canvas default&quot;}\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">filed <\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=XB7XSq2bFz7_Fcm4mM392dQuUZSLkRjIibvEFIqGH3EAsvcdM_0_tW29Mcc4kBpDKPJWMC12RQ-7OXQEOwBt3NlJeT_bhr87EtlVc38_vnTqPbErTHtydm59Y_aRpOHcEbCZ3uyqFAPBp9MtJRByAWDMukIcSfaI2QqY2iHJiPw=\" data-ylk=\"slk:cyber%20incident%20details;elm:context_link;itc:0;sec:content-canvas;source:content-canvas%20default\" data-yga=\"{&quot;yLinkText&quot;:&quot;cyber incident details&quot;,&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yTrafficOrigin&quot;:&quot;content-canvas default&quot;}\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">cyber incident details<\/a> with the Pentagon and federal authorities. Officials confirmed that the trial&#8217;s localized, air-gapped LoRaWAN architecture prevented any exposure, keeping the data-telemetry environment secure. Meanwhile, postgraduate students and licensed professionals can apply for international <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=2jiZv5xMPzADOluurY_3IFYIo062KAq4ERQGK68xI0gJOajx2t4EjbgfknpNxqpvKX9UvTNr-iaVicQYEod1s63E5LVBvGryjXA-YFJL-jI=\" data-ylk=\"slk:work-study%20programs;elm:context_link;itc:0;sec:content-canvas;source:content-canvas%20default\" data-yga=\"{&quot;yLinkText&quot;:&quot;work-study programs&quot;,&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yTrafficOrigin&quot;:&quot;content-canvas default&quot;}\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">work-study programs<\/a>. Academic tracks feature a 220 clock-hour certification course covering enclave law and zero-trust security. Full trial details and updates are accessible via recovery.org and ClinicalTrials.gov.<\/p>\n<p>Read full story: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=6fh5ZYNo1q2TH6NoIwkasHMf9sYTJCXTTIG9sa6oYHFl_139BX6pyAe_v2cjZv-2n8ixqdowZczLD2XpSgtKOSQlWanagBt3tMeCEWMhoDWsQjjnO7-koF_OFCvk5hSPH3jFfEttI_HzERhrCOQAQ2jYaeFWq9VKBFSJ2zxSUs8RzhuVql5wQi99TWjhJG_RJgN3fs70ecZOLTqZZvnFIpkpa8LKTgIQMtbyrcP5zovbcc0Rv1J6gd2KkOVX0-EtjedKxRr7j6Bb-QNpczjpiylCWbgqCkJT9zftjTl44QMP8yNZ1WIzwOIZLgtNFG5d9LzukCVOh-Qz2Roiwg6d_BVRVegHYoD8K-TeaNPGPh8=\" data-ylk=\"slk:Q-Men%3A%20AGI%20Robots%20Digital%20DNA%20%26%20Cyber%20Labor%20%E2%80%94%20QAIAx%204E%20Myths%20%26%20Facts;elm:context_link;itc:0;sec:content-canvas;source:content-canvas%20default\" data-yga=\"{&quot;yLinkText&quot;:&quot;Q-Men: AGI Robots Digital DNA &amp; Cyber Labor \u2014 QAIAx 4E Myths &amp; Facts&quot;,&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yTrafficOrigin&quot;:&quot;content-canvas default&quot;}\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">Q-Men: AGI Robots Digital DNA &amp; Cyber Labor \u2014 QAIAx 4E Myths &amp; Facts<\/a>  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">Related Topics &amp; Further Reading<\/p>\n<p><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=o4M1hlcVIsVOz5NbPFVnfU7fsYVHT8jNF2Rnn0PcdiWs6OxIXxyOrK82HBEao9KX8r98_db9ZfsGy3I6VFKmPwsSF9Klb413Z28h4K46MKk_Cw1iXZ4bMFJxlikJemIvntmnHTa7tSoikJ_Zd7ACM5SrIbaaAyaqcUO3XLQrEJwaOVUVV_hIG59MANmJbEL2M37oLbHYmurMzucnaCs5h9VNIfcVZqAPQVoXjb0W7vlFdVAeaIEjPrRGnVcwEW3TDoEO5gC1y1hw9JAqLLs29Aby0R-hV4xn3y5yOPIVyp3Jiv-5luWPJttSxDiCKEfGDjYmP-2Sx9geE3rXuUN92Q==\" data-ylk=\"slk:QAIAx%20Program%20Press%20Statement%20-%20Pre-Launch%20Phase%20Participant%20%26%20Sponsor%20Detail%20(Veterans%20Recovery%20Network%20-%20August%2010%2C%202026);elm:context_link;itc:0;sec:content-canvas;source:content-canvas%20default\" data-yga=\"{&quot;yLinkText&quot;:&quot;QAIAx Program Press Statement - Pre-Launch Phase Participant &amp; Sponsor Detail (Veterans Recovery Network - August 10, 2026)&quot;,&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yTrafficOrigin&quot;:&quot;content-canvas default&quot;}\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">QAIAx Program Press Statement &#8211; Pre-Launch Phase Participant &amp; Sponsor Detail (Veterans Recovery Network &#8211; August 10, 2026)<\/a>  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\"><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=o4M1hlcVIsVOz5NbPFVnfXOj8RLBXlbeI8GH4D2bTnJ2D4Fl6l8ESYvUbluiFYUfaWbVU7CIcHJBJ5Wqu5nJa_I2ZHoR_buO-6qMEpVj-ob4vCMYSOUqpLE8JlT6Lw6jUAkxQxtmk0jcKULXfbAEE9pCuGuijo_S2c38ZqrMXb_afcEFdM-27bhKMntcEgcn1yuitmENnSk9skHkfOEcVQ==\" data-ylk=\"slk:QAIAx.org%20-%20Official%20Clinical%20Trial%20Details%20(ClinicalTrials.gov%20%E2%80%94%20NCT07661823);elm:context_link;itc:0;sec:content-canvas;source:content-canvas%20default\" data-yga=\"{&quot;yLinkText&quot;:&quot;QAIAx.org - Official Clinical Trial Details (ClinicalTrials.gov \u2014 NCT07661823)&quot;,&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yTrafficOrigin&quot;:&quot;content-canvas default&quot;}\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">QAIAx.org &#8211; Official Clinical Trial Details (ClinicalTrials.gov \u2014 NCT07661823)<\/a><\/p>\n<p><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=i76FYYfsYxMqX86Hqo4bG18M8UAveDDegxRHtQWM0Svlu2f8-wq0qbynwvP_rcxxShOyRfKTH1Rrz8vJrkgGdNM5rMJ7OdYkiRLCRkCSel4QFcBXCCwOG0-DzrTNeVJQqTlHTzoly0hJjyLAE-nCDNfpNo7zLVEgNyl8miW2UV-_mvIr7lJ-Jl6rT5HkJePsHr_kkbfdwjMxhR2gLqMjgYQtMH2GbkTX4hbDNo-dk8s=\" data-ylk=\"slk:Interesting%20Engineering%3A%20New%20&#039;Digital%20DNA&#039;%20Project;elm:context_link;itc:0;sec:content-canvas;source:content-canvas%20default\" data-yga=\"{&quot;yLinkText&quot;:&quot;Interesting Engineering: New &#039;Digital DNA&#039; Project&quot;,&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yTrafficOrigin&quot;:&quot;content-canvas default&quot;}\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">Interesting Engineering: New &#8216;Digital DNA&#8217; Project<\/a>  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\"><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=p9E264PAjminiQ5SA1mEQ-XpTFElNUWL4HPR-rjlqi_TH1oGd_b6kKifQ-QEP-f92II2bgJUNqzEBA63izElQQjIYg3yjTjGjmboxu50LaHNp-5rHXUypqyDGoKzhyEr4-wkGf1HHb9XRe4cT3ujHYVu67mNGeatX2udbV_1dA8veFRKudVic5mp0fnASTTTyAolqkOlgjJx8EZ51s-x-t491ntOB7U0htrrLFiJWUJOudVHuU--uwypsRQpUJHnJuaOzNJwGbQQ1ulfC6mb23kA0t3s4ynbUOTU_7mkUf3YPu4Q0_SCaN6zYZG85RFi\" data-ylk=\"slk:Mjengo%20Hub%3A%20Haptic%20Suit%20Project%20Aims%20to%20Keep%20Human%20Identity%20Alive%20in%20Robots%20After%20Death;elm:context_link;itc:0;sec:content-canvas;source:content-canvas%20default\" data-yga=\"{&quot;yLinkText&quot;:&quot;Mjengo Hub: Haptic Suit Project Aims to Keep Human Identity Alive in Robots After Death&quot;,&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yTrafficOrigin&quot;:&quot;content-canvas default&quot;}\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">Mjengo Hub: Haptic Suit Project Aims to Keep Human Identity Alive in Robots After Death<\/a><\/p>\n<p><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=6yMRrZDxujuULU6gBB4lCu0LQzMOoo_eEXUZ_eY4btn85vOaw2wBZ0azFR2K1-zGpgkqFEN5eR3BUBFVL9JgolOoqBEGmhdykJURijIK64JpObjTy5zCgbslxmdvK0LDBSIzNO7wjJoAR9CkZX4gNLrm04szUYNqZc8kGKtI__QfpaQBgq8_dfl91Mw7dUNEauM1jKOvI_4AU4ahu_joeLC_-YiXhJLqaksFGAsHoApdnm6nZWyFdOrWhf-5HrXF\" data-ylk=\"slk:(Video%20Content%20Channel)%20QAIAx%20Clinical%20Trial%20Microcities%20%E2%80%94%20General%20Program%20Details;elm:context_link;itc:0;sec:content-canvas;source:content-canvas%20default\" data-yga=\"{&quot;yLinkText&quot;:&quot;(Video Content Channel) QAIAx Clinical Trial Microcities \u2014 General Program Details&quot;,&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yTrafficOrigin&quot;:&quot;content-canvas default&quot;}\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">(Video Content Channel) QAIAx Clinical Trial Microcities \u2014 General Program Details<\/a><\/p>\n<p><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=HqfNXjagUI46fr-4eEI4tp4z2UzgKOJMpOipPjr1xlIuhO4DoyWrf_L0RquPNgiGorTDvl4G_VLSOOsPiRuJw63HlFUQSRnHNOvRRZLzZ93d-iPGquXRK1Qr7Ka7tqjjplkiGFYo1RElHo49TVKazaKiewvHxX5DBURKX1gM60ArfhjSBufV2jHHDZA2z_WQHGWdIwmp9Au8SMNOie_TTmLq4CUJWb8TafuZJyPC_TE012dJUa8cUYc0sla3rB1ngFjICnvLili_0ZFLJUmziOCxx6ntMVmLrOdBFVEbzcZI6hZ6k7-NCJeM81VkryRmyYyMdIzqdmo7Qg6pQlTA9G0OmnVgb6R_-K3ZU8-sIg0=\" data-ylk=\"slk:GlobeNewswire%3A%20Inside%20the%20World&#039;s%20First%20AGI%20Smart%20Health%20Cities;elm:context_link;itc:0;sec:content-canvas;source:content-canvas%20default\" data-yga=\"{&quot;yLinkText&quot;:&quot;GlobeNewswire: Inside the World&#039;s First AGI Smart Health Cities&quot;,&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yTrafficOrigin&quot;:&quot;content-canvas default&quot;}\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">GlobeNewswire: Inside the World&#8217;s First AGI Smart Health Cities<\/a><\/p>\n<p><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=nIS94mqpQITsP0FuNXDx41NbP2Vapi4lrlTzRcRQ9z9KVRXqqiue8q-jmBKjPd7omc3eq5tVdsdU91RWW8TnXfB8r2gYoq-FTnUQki0IbwxjaHvU7oQvbtGU72iKOsEWMu0WERWa-Ab4aHQ0OBzqSpvWJ0lvPfXWmVuTMORD5jJYZH2VpdPTMgt0SjYfKCQQIoXT1khsM9L-jcrt_xaVK1z-IBjxHmosejgWFO37n0MizEpHmiecvBD8WfYvDqMfEOQGQefindiZOk71BbKFPhL8_4oQ213Wx_Rbo_76nZA=\" data-ylk=\"slk:Robotics%20Business%20Review%3A%20AI-119%20Vulcan%20Proposes%20Hybrid%20AI%20Governance%20System;elm:context_link;itc:0;sec:content-canvas;source:content-canvas%20default\" data-yga=\"{&quot;yLinkText&quot;:&quot;Robotics Business Review: AI-119 Vulcan Proposes Hybrid AI Governance System&quot;,&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yTrafficOrigin&quot;:&quot;content-canvas default&quot;}\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">Robotics Business Review: AI-119 Vulcan Proposes Hybrid AI Governance System<\/a>  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">Veterans First for America is a non-partisan Veterans&#8217; rights awareness advocate for events and activities that support the American military veteran community.  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">A photo accompanying this announcement is available at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Bf5j346KVNziTZE078EmKXJeCSzOAivmSutn912Os1Sk51_xx6tEgO37VQxVIEG1bqmTgnEba7HLgWFe97ANH4OkLitWFRLwxjBpJdD0K7JUyBexwy7dvhTqrnz_U5Gp4__KXKFjjHasrr9hlwdpw3Ew1U_KQgDPAsCxy4kXXgITidUo6ezz2XD7-MEDnGTVdwg6YTxihSSZJQ3ycTpIqpaK6-VY4npUwCpSGZ8l4PsGqNfvZRb1Oz7Dd4ZFsoS0SyznuFwOUsgAMXdlPC72xg==\" data-ylk=\"slk:https%3A%2F%2Fwww.globenewswire.com%2FNewsRoom%2FAttachmentNg%2F4203fdc1-b579-4901-9a6f-f178211b7615;elm:context_link;itc:0;sec:content-canvas;source:content-canvas%20default\" data-yga=\"{&quot;yLinkText&quot;:&quot;https:\/\/www.globenewswire.com\/NewsRoom\/AttachmentNg\/4203fdc1-b579-4901-9a6f-f178211b7615&quot;,&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yTrafficOrigin&quot;:&quot;content-canvas default&quot;}\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">https:\/\/www.globenewswire.com\/NewsRoom\/AttachmentNg\/4203fdc1-b579-4901-9a6f-f178211b7615<\/a>  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">A video accompanying this announcement is available at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Bf5j346KVNziTZE078EmKXJeCSzOAivmSutn912Os1Sk51_xx6tEgO37VQxVIEG1Mt_72CT8PZjjo_Jqpeua9cfirxeoOuckMvE1xCzZZ-ebL1CJFqRkd1_mg_rbID5mYvVqipYnVN8A9y-NjJiDR4m_cpQkMUBcIzu-eBgFsNFXLELD4Ke45KDb7TjYcI8fImrtQJMVhOQgE0-m1nWMroVNFcPuxpyeBO07E7lhpWikj0AlK2nSiwA0tWf3eXEJK9bnOrwUMtMd038ftM10PQ==\" data-ylk=\"slk:https%3A%2F%2Fwww.globenewswire.com%2FNewsRoom%2FAttachmentNg%2F7fcc0135-5cd6-4678-ae21-2c614348b8a3;elm:context_link;itc:0;sec:content-canvas;source:content-canvas%20default\" data-yga=\"{&quot;yLinkText&quot;:&quot;https:\/\/www.globenewswire.com\/NewsRoom\/AttachmentNg\/7fcc0135-5cd6-4678-ae21-2c614348b8a3&quot;,&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yTrafficOrigin&quot;:&quot;content-canvas default&quot;}\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">https:\/\/www.globenewswire.com\/NewsRoom\/AttachmentNg\/7fcc0135-5cd6-4678-ae21-2c614348b8a3<\/a>  <\/p>\n","protected":false},"excerpt":{"rendered":"Video Content: QAIAx Microcities Clinical Trial (General Program Details) QAIAx CT &#8211; (Clinical Trial Updates from Key Sponsor)&hellip;\n","protected":false},"author":2,"featured_media":136303,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[6744,3013,6418,11138,51,46225,67552,60384,67553,67551],"class_list":["post-136302","post","type-post","status-publish","format-standard","has-post-thumbnail","category-agi","tag-agi","tag-artificial-general-intelligence","tag-global-network","tag-humanoid-robotics","tag-mental-health","tag-microcities","tag-military-installations","tag-military-veterans","tag-program-administration","tag-program-updates"],"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/posts\/136302","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/comments?post=136302"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/posts\/136302\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/media\/136303"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/media?parent=136302"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/categories?post=136302"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/tags?post=136302"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}